Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

First Page		Document Content
Date: 2013-06-10 09:30:24 Cyclopyrrolones Neuropsychology Imidazopyridines Organochlorides Sanofi Zolpidem Eszopiclone Intermezzo Zaleplon Nonbenzodiazepines Chemistry Organic chemistry		Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed] Add to Reading List Source URL: www.kdheks.gov Download Document from Source Website File Size: 121,34 KB Share Document on Facebook

	Use of High-Risk Medications in the Elderly (HRM) Description The percentage of patients 65 years of age and older who received two or more prescription fills for a high-risk medication during the measurement period. De DocID: 1pqJQ - View Document
	This fact demonstrates that the veenat tab combination is safe. Do not drive or do things that you can compare to your doctor has given you. Similarly, chlorpromazine in combination with complementary preparations or vit DocID: 1ougf - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LUNESTA safely and effectively. See full prescribing information for LUNESTA. LUNESTA® (eszopiclone) tablets, for o DocID: 1cLNL - View Document
	/opt/Dropbox/BiomedicalSemanticsSubmission/Figures/future-connected-claims-to-package-insert.dia DocID: 13Fmt - View Document
	WHAITCA AMEARTS E SUMMER GRILLING GUIDE DocID: 12SB3 - View Document